Open application window

Translational Research in Maternal and Pediatric Pharmacology and Therapeutics (R21 Clinical Trial Optional) deadline 2026

The current listed application deadline is May 7, 2026. Use this page to verify timing fast, then move into the full grant record for planning, comparison, and drafting.

Agency
National Institutes of Health
Award range
Not specified
Total funding
Not specified
Funding instrument
Grant
CFDA / ALN
93.279, 93.313, 93.855, 93.865
Cost share
No

Application Countdown

48
Days
14
Hours
30
Minutes

Use this page as the fast check for timing, then jump into the full grant record for filters, drafting, and comparison.

Quick facts

Opportunity number
PAR-25-111
Last updated
March 31, 2025
Expected awards
Not listed

Deadline summary

The purpose of this notice of funding opportunity (NOFO) is to support translational and clinical research to (1) advance precision medicine in pregnant women, lactating women, and children through the development of novel tools, models, and other technologies that could have a direct clinical or health impact; (2) enhance the understanding of the underlying mechanisms of drug action, including the role of pediatric ontogeny and the dynamic physiological changes that occur during pregnancy and l...

Key dates

Posted
November 18, 2024
Deadline
May 7, 2026

Before you apply

Confirm the official submission path and any portal requirements.
Review the close date carefully and account for agency timezone handling.
Validate fit against the listed eligibility groups before investing drafting time.
Compare adjacent opportunities if this deadline window feels too narrow.

Eligibility snapshot

000102040506

Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.